A pilot social media program at Roswell Park aims to help adolescent and young adult cancer patients and survivors, by providing a safe online space to share their thoughts and know that they are not alone.

Two-time cancer survivor, Elyse NeMoyer, explains how research helped save her life.

From the day Roswell Park was founded in 1898, we’ve focused exclusively on understanding, preventing and treating cancer. But along the way, our work has led to major benefits for patients with other medical conditions — and created valuable tools for researchers in other fields of healthcare.

One reason this finding is so exciting is that we can now focus on the X chromosome to find the gene mutations that put women at higher risk of ovarian cancer and men at higher risk of testicular cancer.

Prospective employers expressed doubt that she was really a nurse or emphasized that even if she were hired, she would not receive the same pay as the white nurses and would have to eat alone, in the kitchen. Those roadblocks were no match for the determination of Eva Bateman.

One day in 1955, Dr. James Grace’s two-year-old son, Jimmy, spiked a fever of 105°. It was the first sign that the little boy had acute leukemia — a fast-moving disease that in those days had no hope of a cure. When his son died only a few months later, Dr. Grace converted his pain to passion.

As we celebrate the 120th anniversary of Roswell Park Comprehensive Cancer Center, we recognize that what we have accomplished would have been impossible without the financial support of our community.

In the 1950s, nothing much could be done for patients with acute lymphoblastic leukemia (ALL). Dr. Jim Holland was determined to change that.

On January 29, the Food and Drug Administration approved a lutetium Lu 177 dotatate (Lutathera^®), a targeted radiation drug, for the treatment of gastroenteropancreatic neuroendocrine tumors.